INTS 2020 Sponsors & Exhibitors

The 2020 International Neurotrauma Symposium Organising Committee wishes to thank the below organisations for their support and contribution.

Major Sponsor

Lunchtime Seminar Sponsors

Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa®, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Simoa is designed to enable much earlier disease detection, better prognoses, and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including neurology, with instrumentation and ultra-sensitive assays developed to measure neuronal and neuroinflammatory biomarkers in blood and CSF. The company was established in 2007 and is located in Billerica, Massachusetts. For additional information, please visit https://www.quanterix.com.    

Education Sponsor

 

 

The EBIC consortium includes many leading research centres from Europe and was established as a company with charitable status in 1995. Since then EBIC has collaborated with industry and academic partners in both the development and management of important projects, including key clinical trials in neurotrauma.
EBIC also produced early guidelines for the management of TBI with the aim of harmonizing treatment across participating centres, and a prospective EBIC survey yielded research outputs which addressed epidemiology and practice of neurotrauma care in Europe.  EBIC Executive Members were key players in securing the funding for CENTER-TBI, a European Union-funded, €30 million precision medicine and comparative effectiveness research study in TBI.  EBIC activities have been on hold while we have focused on CENTER-TBI, which will be completed in 2021.
The Wicking Dementia Research and Education Centre is a global leader in dementia research and education; with a mission to transform the understanding of dementia worldwide and to build a workforce to lead positive change in ageing and dementia care.  The Wicking Dementia Centre research focusses on the cause, prevention and care of dementia. The Centre has a substantial research interest in traumatic brain injury as a risk factor for dementia, including work on experimental models, clinical cohort studies, as well as in educational programs.
 
Traumatic brain injury is often described as a silent epidemic, with approximately 69 million cases occurring each year. Understanding Traumatic Brain Injury (TBI) is a free online course that aims to raise awareness and build knowledge to reduce risk as well as improve management and rehabilitation outcomes for people who have experienced a TBI. This free MOOC (Massive Open Online Course) has been developed in conjunction with Vision TBI Ltd and looks at the causes and consequences of TBI across the spectrum from mild concussion through to severe injuries, as well as the types of injuries and frequency at which they occur across the lifespan. The MOOC will be available in March 2021.

Bursary Sponsors

The NRP brings together neuroscientists, neurosurgeons, and clinicians in unprecedented collaborative scientific endeavours and provides seed funding for unique and vital neurotrauma research.  The NRP is the only WA-based funding body for brain and spinal cord injury research.
The world-class scientific research of the NRP is aimed at improving the lives of people affected by neurotrauma and the wider community, recognising the medical, social and psychological ramifications of these injuries. Specifically, the NRP supports research into avoiding, understanding injury mechanisms and developing effective treatments for acquired trauma to the nervous system (brain and spinal trauma). 

For further details or to get in touch, please email nrp@perron.uwa.edu.au or visit https://neurotraumaresearchprogram.org.au/

The Transport Accident Commission (TAC) is a Victorian Government-owned organisation whose role is to support those injured on our roads and promote road safety.
The TAC’s mission is to be the world’s leading social insurer, providing medical, rehabilitation and financial support to help people get their lives back on track after a transport accident.
The TAC works closely with Victoria Police, the Department of Justice and VicRoads to promote road safety. It develops campaigns that increase awareness of road safety issues, change behaviour and ultimately reduce the incidence of road trauma.

Session & Bursary Sponsors

Part of Curtin University’s Faculty of Health Sciences, the Curtin Health Innovation Research Institute (CHIRI) is working to identify new treatment strategies for adult diseases by supporting researchers who are prepared to explore the unexplored and take risks in research in search of major scientific insights and adult health outcomes.

CHIRI’s research is focused on four key areas, covering major disorders and diseases that impact on the quality of adult life, including neuroscience-focused lines of research inquiry.

Research focus:
– Vascular and metabolic disorders
– Inflammation, infectious disease and wounds
– Neurodegenerative disorders
– Cancer

Visit the CHIRI website at chiri.curtin.edu.au for all the latest news from our institute, researcher profiles and to subscribe to receive our updates. You can also find us on Twitter (@CHIRI_curtin) and Facebook (@CurtinCHIRI). 

The Perron Institute for Neurological and Translational Science (formerly the Western Australian Neuroscience Research Institute – WANRI) is Western Australia’s longest established medical research institute. We undertake cutting edge research on a broad spectrum of conditions including stroke, Parkinson’s, motor neurone disease, muscular dystrophy, myositis and multiple sclerosis.

One of our special strengths is the connection between the Institute’s laboratory research and its 15 specialist clinics. This multidisciplinary approach enables us to translate research outcomes into treatments aimed at providing a better quality of life for millions of people around the world who suffer with devastating neurological conditions.

Young Investigators Awards Sponsor

Offering world-class teaching in Medicine, Public Health and Biomedical Sciences, as well as incorporating five leading clinical research institutes and centres, the Faculty of Medicine is a major force in medical education and translational research in Australia, including in the areas of traumatic brain and spinal cord injury.
For more information please visit:
https://medicine-program.uq.edu.au/
https://public-health.uq.edu.au/
https://biomedical-sciences.uq.edu.au/

Faculty of Health and Medical Sciences Early Career Research Award, The University of Adelaide

The Faculty of Health and Medical Sciences at the University of Adelaide is a world leader in health education and research. The faculty seeks to improve health care in Australia and internationally and contains one of Australia’s largest concentrations of leading health researchers, teachers and clinical titleholders. Through the integration of teaching and research, our graduates are equipped with the knowledge, skills and capabilities to not only deliver the best care, but be tomorrow’s health leaders. Our researchers lead transformative investigations that generate a rich stream of new insights, innovative technologies and treatments and improved policy. Through our international research partnerships, we are improving health outcomes across the globe.

Session Sponsor

SpinalCure is Australia’s premier nationally operating advocate promoting and funding research towards a cure for spinal cord injury. We are:

• Committed to making a cure for spinal cord injury not only achievable but available.
• Funding breakthrough technologies, data, and creative thinking.
• Supporting those who question the old science and embrace the new.
• Collaborating with powerful partners who share our bold vision.
• Investing in results and for maximum impact.

Pen Sponsor

 

Destination Sponsor

Exhibitors

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for clinicians, so they can concentrate on providing the best patient care. We offer innovative solutions in neurosurgery, tissue regeneration and reconstruction and surgical instruments.
Our neurosurgery portfolio is a global leader in tissue ablation, hydrocephalus management, neurocritical care and dural access & repair with products and brands such as CUSA®, Codman® Certas® Plus, Bactiseal® Cerelink®, Duragen® and Duraseal®. Our tissue regeneration and reconstruction portfolio includes unique solutions for nerve repair, dermal regeneration and breast reconstruction with products including Neuragen®, Integra® Dermal Regeneration Template, Primatrix® and Surgimend PRS®, while our surgical instruments portfolio provides solutions across specialties with products including Mayfield®, Omni-Tract®, MicroFrance® and Luxtec®.
Since 1886 Stoelting (www.StoeltingCo.com) has been a leader in the development, design, and sale of neuroscience research equipment. Our line of Stereotaxic Instruments, accessories and expertise is world-renowned and unrivaled. Moreover, the intuitive, friendly design, rich features, and all-inclusive technical support of Stoelting’s behavioral tracking software ANY-maze (www.ANY-maze.com) allows you to track literally any animal virtually anywhere. Furthermore, ANY-maze can be used to customize and automate your creations by detecting and respond to inputs from levers, photo-beams, running wheels, etc. Tech support and upgrades are free. We also offer solutions for Animal Identification including Ear Tags and Markers. Contact: Neuro@StoeltingCo.com
GeneWorks has supplied the Australian research community with cutting edge technologies and reagents for over 20 years.

GeneWorks proudly represent Quanterix, who’s Simoa technology digitizes ELISA and offers unparalleled sensitivity enabling the detection of biomarkers of neurotrauma and neurodegenerative diseases in blood.